Gene therapy shows promise for arrhythmogenic cardiomyopathy

Researchers evaluated the effectiveness of adeno-associated virus (AAV)-mediated Plakophilin 2 (PKP2) delivery in treating arrhythmogenic cardiomyopathy (ACM).

Related Keywords

Netherlands ,Dutch ,Underhilstudio Shutterstock ,University Of California San Diego ,Roswell Park Memorial Institute ,Stanford Cardiovascular Institute ,Nature Cardiovascular Research ,California San Diego ,Transforming Growth Factor Beta ,Graphpad Prism ,Cardiomyopathy ,Gene ,Gene Therapy ,Albumin ,Antibodies ,Ntibody ,Ascorbic Acid ,Fell ,Efficacy ,Genes ,Enetic ,Heart ,Heart Failure ,N Vitro ,N Vivo ,Muscle ,Utation ,Protein ,Research ,Transplant ,Virus ,